Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 24, 2017
Pharmacy Choice - News - Generic Drugs - March 24, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/31/16 - LUPIN GETS USFDA NOD FOR PITAVASTATIN TABLETS
Pharmaceutical company Lupin has received tentative approval from the United States Food and Drug Administration to market its cholesterol lowering Pitavastatin tablets in the American market. has received approval for Pitavastatin tablets in the strength of 1 milligram, 2 mg and 4 mg. Pitavastatin is a generic version of Kowa's Livalo tablets in t
12/30/16 - Aurobindo Pharma gets US FDA approval for 2 drugs, stocks up 3% [India Infoline News Service]
Aurobindo Pharma has received US Food and Drug Administration's approval for two of its generic drugs, following which the company stocks gained positive traction. Aurobindo Pharma has received US Food and Drug Administration's approval for two of its generic drugs, following which the company stocks gained positive traction. Aurobindo Pharma Ltd i
12/30/16 - Intellipharmaceutics to Present at the Biotech Showcase [Daily Star, The (Lebanon)]
-Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the Company is scheduled to present at the annual Biotech ShowcaseTM conference on January 11, 2017.
12/30/16 - Mylan Posting Strong Gain After Launching Generic Concerta, Cerebyx
CANONSBURG- Mylan is posting a strong gain in afternoon trading on Friday, with shares of the drug maker climbing by 2.5 percent. The gain by Mylan comes after the company announced the launch of a generic version on Johnson& Johnson's Concerta tablets for the treatment of Attention Deficit Hyperactivity Disorder. Mylan also announced the launch of
12/30/16 - Pharmaceuticals Newsletter - December 26 to 30, 2016 [India Infoline News Service]
This week, Lupin received tentative approval for generic Giazo Tablets, Aurobindo Pharma got US FDA approval for 2 drugs and Glenmark Pharma gets USFDA approval for Tretinoin Capsules. Lupin receives tentative approval for generic Giazo Tablets Pharma Major Lupin Limited announced that it has received tentative approval for its Balasalazide Disodiu
12/29/16 - Abbott Laboratories, et al.; Withdrawal of Approval of Four New Drug Applications and Two Abbreviated New Drug Applications
FOR FURTHER INFORMATION CONTACT: Florine P. Purdie, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 6248, Silver Spring, MD 20993-0002, 301-796-3601.. SUPPLEMENTARY INFORMATION: The holders of the applications listed in the table have informed FDA that these drug products are no longer
12/29/16 - Clinical Pharmacology Data To Support a Demonstration of Biosimilarity to a Reference Product; Guidance for Industry; Availability
SUMMARY: The Food and Drug Administration is announcing the availability of a guidance for industry entitled "Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product." This guidance is one in a series of guidances that FDA is developing to implement the Biologics Price Competition and Innovation Act of 2009.
12/29/16 - Intellipharmaceutics to Present at the Biotech Showcase?
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the Company is scheduled to present at the annual Biotech Showcase TM conference on January 11, 2017.
12/29/16 - Lupin receives tentative approval for generic Giazo Tablets [India Infoline News Service]
Lupin's Balasalazide Disodium tablets 1.1 gm are the AB rated generic equivalent of Salix Pharmaceuticals Inc's Giazo Tablets, 1.1 gm.Pharma Major Lupin Limited announced today that it has received tentative approval for its Balasalazide Disodium Tablets, 1.1 gm from the United States Food and Drug Administration to market a generic version of Sali
12/29/16 - Mylan Launches Generic Cerebyx Injection
HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2016/ PRNewswire/ Mylan N.V., today announced the U.S. launch of Fosphenytoin Sodium Injection USP, 75 mg/mL,, packaged in 100 mg PE*/ 2 mL, and 500 mg PE*/ 10 mL single-use vials, a generic version of Pfizer's Cerebyx Injection. Fosphenytoin Sodium Injection USP, 75 mg/mL,, packaged in 100 mg PE
12/29/16 - Mylan Launches Generic Concerta Tablets
HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2016/ PRNewswire/ Mylan N.V., today announced the U.S. launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a generic version of Janssen's Concerta Tablets. This launch also further strengthens our robust portfolio of central nervous system medicati
12/28/16 - Beijing buyers club? China's cancer patients gamble on grey market [Peninsula, The (Qatar)]
SHANGHAI: When her father's lung cancer worsened, Yin Min, a 51- year-old financial broker from Shanghai, faced a choice: pay nearly $3,000 a month for an approved drug or pay a fraction of the price for a generic drug not approved for use in China. Yin, like many families in China, turned to the increasingly popular, unregulated market of online p
12/28/16 - Concordia International Corp. Announces Leadership Transition at International Segment
-Concordia International Corp., an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, today announced that effective January 1, 2017, John Beighton will retire from his current role as President of the Company's International segment. Mr. Duncan joined Amdipharm Mercury Limited in.
12/28/16 - Congress ignores drug safety with CREATES Act
Over 60 percent of Americans want the government to take action to lower prescription drug prices, according to a new Kaiser Family Foundation survey. Congress, for once, is listening to voters. To protect consumers, the FDA requires that new drugs undergo a series of clinical trials to prove their safety and effectiveness before entering the marke
12/28/16 - GLENMARK GETS FDA NOD FOR LEUKAEMIA TREATMENT DRUG
Glenmark Pharmaceuticals has received final approval from the US Food and Drug Administration for selling its generic version of tretinoin capsules 10 mg. The drug is used for the treatment of leukaemia. Tretinoin capsules are the generic version of Vesanoid Capsules 10 mg of Hoffmann La Roche Inc. The drug is no longer marketed in USA..
12/28/16 - Mylan Launches Generic Zovia Tablets
HERTFORDSHIRE, England and PITTSBURGH, Dec. 28, 2016/ PRNewswire/ Mylan N.V., today announced the U.S. launch of Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg/ 0.05 mg. Mylan's subsidiary, Jai Pharma Limited, received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product
12/28/16 - Serial testers and cursory checks: India's flawed generic drug trials business [Peninsula, The (Qatar)]
A woman talks on a mobile phone as she walks past the closed research facility of Semler Research Centre in Bengaluru, India, October 13, 2016. HYDERABAD: Vasudeva Prakash left his job as a mechanic in Hyderabad three years ago for what he calls a more lucrative career: taking part in clinical trials on generic drugs. Prakash provided documentation
12/28/16 - Voxello Announces the Election of Richard Wieland to the Company's Board of Directors
Most recently, Rich was Executive Vice President and Chief Financial officer of Unilife Corporation, a NASDAQ- traded medical device company. His first CFO position was with LyphoMed Inc., a generic pharmaceutical company with revenues of~ $225 million that was eventually acquired by Fujisawa Pharmaceutical Co. Ltd. Rich began his career at Procter
12/27/16 - Credence Research: Global Biosimilars Market Size, Share, Growth, Outlook, Analysis and Forecast to 2015-2022: Brisk Insights
According to a recently published report, the Biosimilars Market is expected to grow at the CAGR of 22.6% during 2015-2022. The segmentation of global biosimilars market is based on product type, application, technology, services and geography. The report on Global Biosimilars Market Forecast, 2015-2022 provides detailed overview and predictive ana
12/27/16 - Generic prescription drugs better for the country
According to data from OECD, the average American spent nearly $1,100 a year on pharmaceuticals, nearly $400 more than second-place Canada. That high cost is one reason the U.S. spends almost $2,300 more per person in health care costs. However, a study by the University of Cincinnati found that there is a significant placebo effect attached to pay
12/27/16 - Glenmark Pharma gains after USFDA approval for Tretinoin capsules [Daily News Egypt]
Glenmark Pharmaceuticals rose 0.49% to Rs 893.50 at 9:53 IST on BSE after the company said it received abbreviated new drug application approval for Tretinoin capsules. Glenmark Pharmaceuticals Inc., USA received final approval from the United States Food& Drug Administration for Tretinoin capsules, 10 milligrams, the generic version of Vesanoid...
12/27/16 - Investigation uncovers evidence of widespread schemes to inflate drug prices
The high prices Americans might for generic drugs may have been cooked up pharmaceutical salespeople on golf courses, at a New Jersey steakhouse or over drinks at "Girls Nights Out" in Minnesota. "The wining and the dining and the dinners and the social repertoire sort of led to an atmosphere in which follow-up conversations could occur where pric
12/27/16 - Pharmas stumble after six-year run may offer value buys [Daily Tribune (Bahrain)]
Plus, there is pricing pressure on the US generics side, "said Dhiraj Sachdev, senior fund manager at HSBC Global Asset Management. Among mid-cap pharmaceutical companies, Wockhardt is the biggest laggard as it has lost 60% of its value this year due to delay in resolution of the US FDA related issues. Recently, Divi`s Laboratories fell under the F
12/27/16 - Recent Findings from Food and Drug Administration Has Provided New Information about Cancer Research (Statistical Considerations in Evaluating a...
By a News Reporter-Staff News Editor at Cancer Weekly New research on Oncology- Cancer Research is the subject of a report. For more information on this research see: Statistical Considerations in Evaluating a Biosimilar Product in an Oncology Clinical Study. Clinical Cancer Research, 2016; 22: 5167-5170. Clinical Cancer Research can be contacted
12/26/16 - Generic-drug manufactures accused of price fixing
The Food and Drug Administration loves generic drugs. The FDA proclaims that: "When it comes to price, there is a big difference between generic and brandname drugs. In 2010 alone, the use of FDAapproved generics saved $158 billion, an average of $3 billion every week. "
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415